PatentsGlobal
Beren Therapeutics Strengthens U.S. Patent Portfolio with Eight New Issued Patents on Cyclodextrin Therapeutics
Beren Therapeutics has secured eight additional U.S. patents related to its proprietary cyclodextrin-based therapeutics, including adrabetadex, enhancing its intellectual property estate. These patents cover compositions, pharmaceutical formulations, manufacturing processes, and methods of treatment for Niemann-Pick d…
Thursday, August 6, 2026